文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

吲哚菁绿(ICG)在腹部、妇科和泌尿外科手术中的当前应用:一项使用AMSTAR 2工具的meta综述和质量分析

Current applications of indocyanine green (ICG) in abdominal, gynecologic and urologic surgery: a meta-review and quality analysis with use of the AMSTAR 2 instrument.
PubMed 文献 · Surg Endosc · 2023-11-13

本meta综述检索了2013年至2023年发表的116项研究(41篇系统综述和75篇meta分析),评估ICG在腹部、妇科和泌尿外科手术中的应用,并用AMSTAR 2工具进行质量分析。ICG在预防吻合口漏方面显示出明确获益,尤其在结直肠和食管手术后;在妇科肿瘤前哨淋巴结检测方面无明确获益。大多数meta分析质量评为「极低」(34.7%)或「低」(58.7%),仅5篇(6.7%)为「中等」质量,无「高」质量综述。

要点

  • ICG在预防结直肠和食管术后吻合口漏方面有明确获益。
  • 妇科肿瘤前哨淋巴结检测中ICG无明确获益。
  • 多数meta分析质量被评为「极低」或「低」,仅6.7%为「中等」质量。

核心结论

  • 尽管相关文献和综述丰富,外科医生在解读ICG在腹部手术中应用的结果时应谨慎。
  • 未来的综述应注重确保方法学严谨性,建立明确的ICG剂量、给药途径和时机方案,并提高报告质量。
  • 其他数据来源(如登记数据库)和新分析方法(如机器学习)可能有助于增强ICG作为手术决策工具的作用。

研究设计与样本

  • 检索PubMed和Embase至2023年9月,纳入涉及ICG在腹部手术中应用的系统综述和meta分析。
  • 共纳入116项研究,包括41篇系统综述和75篇meta分析,时间跨度为2013年至2023年。
  • 使用AMSTAR 2工具对检索到的meta分析进行质量分析。

主要发现

  • 研究最充分的(亚)专科为结直肠(6篇系统综述,25篇meta分析)、妇产科(9篇系统综述,15篇meta分析)和肝胆胰(4篇系统综述,12篇meta分析)。
  • ICG的给药剂量、途径和时机存在高度异质性。
  • ICG在预防吻合口漏方面有明确获益,尤其在结直肠和食管手术后。
  • 妇科肿瘤前哨淋巴结检测中ICG无明确获益。
  • 根据AMSTAR 2工具,大多数meta分析质量评为「极低」(34.7%)或「低」(58.7%),仅5篇(6.7%)为「中等」质量,无「高」质量综述。

关键数值与推荐

  • AMSTAR 2质量评级:极低质量34.7%,低质量58.7%,中等质量6.7%,无高质量综述。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • ICG的给药剂量、途径和时机存在高度异质性。
  • 大多数meta分析质量评为「极低」(34.7%)或「低」(58.7%),仅5篇(6.7%)为「中等」质量,无「高」质量综述。
  • 作者结论指出外科医生在解读ICG在腹部手术中应用的结果时应谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Indocyanine green (ICG) is an injectable fluorochrome that has recently gained popularity as a means of assisting intraoperative visualization during laparoscopic and robotic surgery. Many systematic reviews and meta-analyses have been published. We conducted a meta-review to synthesize the findings of these studies. METHODS: PubMed and Embase were searched to identify systematic reviews and meta-analyses coping with the uses of ICG in abdominal operations, including Metabolic Bariatric Surgery, Cholecystectomy, Colorectal, Esophageal, Gastric, Hepato-Pancreato-Biliary, Obstetrics and Gynecology (OG), Pediatric Surgery, Surgical Oncology, Urology, (abdominal) Vascular Surgery, Adrenal and Splenic Surgery, and Interdisciplinary tasks, until September 2023. We submitted the retrieved meta-analyses to qualitative analysis based on the AMSTAR 2 instrument. RESULTS: We identified 116 studies, 41 systematic reviews (SRs) and 75 meta-analyses (MAs), spanning 2013-2023. The most thoroughly investigated (sub)specialties were Colorectal (6 SRs, 25 MAs), OG (9 SRs, 15 MAs), and HPB (4 SRs, 12 MAs). Interestingly, there was high heterogeneity regarding the administered ICG doses, routes, and timing. The use of ICG offered a clear benefit regarding anastomotic leak prevention, particularly after colorectal and esophageal surgery. There was no clear benefit regarding sentinel node detection after OG. According to the AMSTAR 2 tool, most meta-analyses ranked as "critically low" (34.7%) or "low" (58.7%) quality. There were only five meta-analyses (6.7%) that qualified as "moderate" quality, whereas there were no "high" quality reviews. CONCLUSIONS: Regardless of the abundance of pertinent literature and reviews, surgeons should be cautious when interpreting their results on ICG use in abdominal surgery. Future reviews should focus on ensuring methodological vigor; establishing clear protocols of ICG dose, route of administration, and timing; and improving reporting quality. Other sources of data (e.g., registries) and novel methods of data analysis (e.g., machine learning) might also contribute to an enhanced role of ICG as a decision-making tool in surgery.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Pantelis AG, Machairiotis N, Stavros S, et al. Current applications of indocyanine green (ICG) in abdominal, gynecologic and urologic surgery: a meta-review and quality analysis with use of the AMSTAR 2 instrument. Surg Endosc. 2023. PMID: 37957300. doi:10.1007/s00464-023-10546-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。